The global self-administered drugs market is anticipated to grow at a significant CAGR during the forecast period. The commercial availability of self-administered drugs is gained through pharmacies and not from healthcare providers. More often, the patient in the form of pill or injections usually undertakes self-administered drugs. Patients suffering from multiple sclerosis, rheumatoid, diabetes, arthritis seem to undertake self-administered drugs.
Self-administered drugs market is driven by change in lifestyle of consumers and government support for development of medical infrastructure in rural areas. Drug advancements and availability of proper healthcare infrastructure supplements the market growth during the forecast period. In addition, FDA approval for self-administered drugs in USA is more likely to enhance the market growth during the forecast period.
By type, market comprises creams, syrups, injectable and tablets. Tablets and injectable account for a larger market share. By the route of administration, the market entails transdermal, nasal, intravenous and oral. Nasal and oral segment leads the market segment due to high preference.
Application segment for the market involves diabetes, cardiovascular disease, pain management and osteoporosis and hormone replacement. By sales channel, the market segmentation comprises direct channel and distribution channel. Geographical segmentation for self-administered drugs market spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North American and European regions are most likely to witness a substantial growth due to rise in patient population and proliferation of market participants.
Asia-Pacific regions are likely to have a robust market share owing to wider availability of patients, advances in diagnosis and manufacturer emphasis on drug quality. Stringent laws and regulations are significantly driving a higher growth for self-administered drug market in these regions. The key players profiled in the self-administered drugs market report are Abbott Laboratories, Antares Pharma Inc, Bristol-Mayers Squibb, Novartis AG, Gilead Sciences and Eli Lilly & Company.
Leading players of Self-administered Drugs including:
• Abbott Laboratories
• Bristol-Myers Squibb
• Novartis AG
• Eli Lilly and Company
• Gilead Sciences
• Antares Pharma
Market split by Type, can be divided into:
• Injectable Drugs
• Inhaled Drugs
• Transdermal Drugs
Market split by Application, can be divided into:
• Cardiovascular Diseases
• Pain Management
• Hormone Replacement
Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel
Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Research Support Specialist, USA